Promising new drug to treat 'deadliest' skin cancer developed

Researchers have developed a new drug to delight malignant melanoma, a deadliest form of skin cancer, Powerful X—ray technology developed on the U.S. Department of Energy’s (DOE’s) national laboratories has revealed new insights into diseases range beginning Alzheimer’s to the swine flu, and, most recently, enabled the finding of a groundbreaking new drug treatment for malignant melanoma.

The drug, Zelboraf (vemurafenib), has newly received Food and Drug Administration (FDA) approval in showing the structures of diseased and disease—causing molecules on their basic level, these extremely bright light source enable scientists toward suggest potential new treatments.

"This technology is a wonderful example of how innovations on our national laboratories lead to discoveries into a wide variety of fields,” said Energy Secretary Steven Chu,"In this case, we are pleased to have been involved during research that have shown great promise in the battle against life—threatening melanoma,” he added the researchers used a system called “macromolecular X—ray crystallography” to develop a drug so as to would prevent the enzyme from doing this.